DOSSIER · 13F Holders · Q4 2025Healthcare · Pharmaceutical PreparationsDefensive growthQuality
SPRY
ARS PHARMACEUTICALS INC
215 institutions still hold ARS PHARMACEUTICALS INC as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 82835W108·Pharmaceutical Preparations·215 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
215 institutions reported SPRY in Q4 2025. DEERFIELD MANAGEMENT COMPANY, L.P. leads at 13.1% of the visible book. +104 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 11
195 more holders available. Log in →